FDA Approves Pfizer COVID-19 vaccine Boosters For High Risk Group

The US Food and Drug Administration cleared a third dose of the Pfizer and BioNTech COVID-19 vaccine for people who are 65 and older, all people at high risk of severe disease, health care workers, and other people at high risk of exposure to COVID-19 at work. The decision only covers the Pfizer and BioNTech […]

Continue Reading